TECENTRIQ 840MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: ROCHE PRODUCTS (INDIA) PVT LTD (ONCOLOGY DIV)

MRP: ₹237540.00

ROCHE PRODUCTS (INDIA) PVT LTD (ONCOLOGY DIV): Tecentriq 840MG Injection, 1 vial, salt atezolizumab 840mg. Its MRP stays at Rs 237,540 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 180,982.86. Group: PD-L1 inhibitor (immunotherapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: IV infusion or (1875 mg) under-the-skin injection in hospital only; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.